Application 202150
- Type
- ANDA
- Sponsor
- HERITAGE PHARMS INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE | TABLET;ORAL | 12.5MG;7.5MG | No | No |
| 002 | MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE | TABLET;ORAL | 12.5MG;15MG | No | No |
| 003 | MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE | TABLET;ORAL | 25MG;15MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 23155-035 | Moexipril hydrochloride and hydrochlorothiazide | Moexipril hydrochloride and hydrochlorothiazide | Heritage Pharmaceuticals Inc. | ANDA | Current |
| 23155-036 | Moexipril hydrochloride and hydrochlorothiazide | Moexipril hydrochloride and hydrochlorothiazide | Heritage Pharmaceuticals Inc. | ANDA | Current |
| 23155-037 | Moexipril hydrochloride and hydrochlorothiazide | Moexipril hydrochloride and hydrochlorothiazide | Heritage Pharmaceuticals Inc. | ANDA | Current |